Skip to main content
Clinical Trials/ACTRN12610000072011
ACTRN12610000072011
Completed
Not Applicable

Transurethral Enucleation and Resection of Prostate and Transvesical Prostatectomy for benign prostate hyperplasia (BPH) patients with prostate volume greater than 80ml, the primary outcomes include International Prostate Symptom Score (IPSS) and Quality of Life Score (QoLS)

xie, keji0 sites100 target enrollmentJanuary 20, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
benign proaste hyperplasia
Sponsor
xie, keji
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
xie, keji

Eligibility Criteria

Inclusion Criteria

  • benign prostate hyperplasia (BPH) with prostate\>80ml: The prostate volume is measured by transrectal ultrasound conform to this equation: the volume equals 0\.52 × (L × W × H), where L is the maximum length (craniocaudal dimension), H is the maximum height (anteroposterior dimension), both were obtained from the sagittal plane, W is the maximum width (transverse dimension) obtained from the transverse plane.

Exclusion Criteria

  • neurologic problem and Bladder stone

Outcomes

Primary Outcomes

Not specified

Similar Trials